These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 7212981)

  • 1. Preclinical pharmacologic investigations on a new group of acridine derivatives with oncostatic activity. I. Acute and subchronic action.
    Giełdanowski J; Wieczorek Z; Kowalczyk-Bronisz SH; Kowalewska D; Błaszczyk B; Skibiński G; Zimecki M
    Arch Immunol Ther Exp (Warsz); 1980; 28(5):735-54. PubMed ID: 7212981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological studies on new oncostatic acridine derivatives. I. Acute and subchronic action.
    Błaszczyk B; Giełdanowski J; Patkowski J; Kowalczyk-Bronisz SH
    Arch Immunol Ther Exp (Warsz); 1979; 27(6):749-63. PubMed ID: 549530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical pharmacologic investigations on a new group of acridine derivatives with oncostatic activity. II. Chronic action.
    Giełdanowski J; Wieczorek Z; Kowalczyk-Bronisz SH; Kowalewska D; Błaszczyk B; Skibiński G; Zimecki M
    Arch Immunol Ther Exp (Warsz); 1980; 28(5):755-76. PubMed ID: 7212982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological studies on 1-nitro-9-alkyl acridine derivatives. I. Acute and subchronic action.
    Kowalczyk-Bronisz SH; Blaszczyk B; Gieldanowski J; Patkowski J; Pelczarska A
    Arch Immunol Ther Exp (Warsz); 1975; 23(3):391-413. PubMed ID: 1217965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical pharmacologic investigations on 1-nitro-9-(dimethylaminopropylamino)-acridine and its N-oxide. I. Acute and subchronic activity.
    Gieldanowski J; Patkowski J; Szaga B; Teodorczyk J
    Arch Immunol Ther Exp (Warsz); 1972; 20(3):399-417. PubMed ID: 5055687
    [No Abstract]   [Full Text] [Related]  

  • 6. Preclinical pharmacologic studies on 1-nitro-9-(dimethylamino)-acridine and 1-nitro-10-(dimethylaminoethyl)-9-acridone. I. Acute and subacute action.
    Pelczarska A; Kowalczyk-Bronisz SH; Blaszczyk B; Gieldanowski J; Patkowski J
    Arch Immunol Ther Exp (Warsz); 1974; 22(6):823-42. PubMed ID: 4451445
    [No Abstract]   [Full Text] [Related]  

  • 7. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
    Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic studies on 1-nitro-9-(5-dimethyl-aminopentylamino)-acridine and 1-nitro-10-(3-dimethylaminopropyl)-acridone. 1. Acute and subchronic action.
    Patkowski J; Kowalczyk-Bronisz SH; Szaga B; Teodorczyk J; Gieldanowski J
    Arch Immunol Ther Exp (Warsz); 1973; 21(5):775-95. PubMed ID: 4771983
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacological studies on new oncostatic acridine derivatives. II. Chronic action.
    Błaszczyk B; Giełdanowski J; Patkowski J; Kowalczyk-Bronisz SH
    Arch Immunol Ther Exp (Warsz); 1979; 27(6):765-76. PubMed ID: 549531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. General pharmacology of recombinant human basic fibroblast growth factor.
    Okumura M; Yajima M; Nishimura T; Ikeda H; Nishimori T
    Arzneimittelforschung; 1996 Jul; 46(7):727-39. PubMed ID: 8842346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. General pharmacological profile of the new cognition-enhancing agent nefiracetam.
    Kitano Y; Makino M; Usui C; Takasuna K; Kasai Y; Hirohashi M; Tamura K; Takayama S; Kojima H; Iizuka H
    Arzneimittelforschung; 1994 Feb; 44(2A):199-210. PubMed ID: 8018090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological actions and acute toxicity of methyl- and phenyl-3-methoxy-4-hydroxy styryl ketones.
    Singh GB; Leach GD; Atal CK
    Arzneimittelforschung; 1987 Jun; 37(6):708-12. PubMed ID: 3663269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxicological profile of a low molecular weight spleen peptide formulation used in supportive cancer therapy.
    Hartleb M; Leuschner J
    Arzneimittelforschung; 1997 Sep; 47(9):1047-51. PubMed ID: 9342421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. General pharmacological properties of the human corticotropin-releasing hormone corticorelin (human).
    Andoh K; Kimura T; Saeki I; Tabata R; Yamazaki S; Eguchi I; Hanazuka M; Horii D; Munt PL; Davis AS
    Arzneimittelforschung; 1994 Jun; 44(6):715-26. PubMed ID: 8053970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunobiological and pharmacological properties of thymus factor X (TFX). I. Biological and pharmacological activity.
    Slopek S; Giełdanowski J; Kowalczyk-Bronisz SH
    Arch Immunol Ther Exp (Warsz); 1980; 28(6):827-51. PubMed ID: 7259453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
    Marsman D
    Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological studies on 1-nitro-9-alkyl acridine derivatives. II. Chronic action.
    Kowalczyk-Bronisz SH; Blaszczyk B; Gieldonowski J; Patkowski J; Pelczarska A
    Arch Immunol Ther Exp (Warsz); 1975; 23(3):415-34. PubMed ID: 1217966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. General pharmacology of the new antimuscarinic compound vamicamide.
    Yamamoto T; Honbo T; Tokoro K; Kojimoto Y; Kodama R; Ohtsuka M; Shimomura K
    Arzneimittelforschung; 1995 Dec; 45(12):1274-84. PubMed ID: 8595084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of rodent-only toxicology for early clinical trials with novel cancer therapeutics.
    Newell DR; Burtles SS; Fox BW; Jodrell DI; Connors TA
    Br J Cancer; 1999 Nov; 81(5):760-8. PubMed ID: 10555743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.